Selected highlights from the American Academy of Neurology annual meeting, Boston, MA, 22-27 April 2023.
April 26 Edition
April 25 Edition
Combining sNfL and cGFAP improves prognostic value
NfL/GFAP changes during anti-CD20 treatment
How is JC virus transmitted?
Does body weight affect B cell kinetics?
Hyperglycemia medications and MS risk
Read More
Periodic assessment of serum neurofilament-light chain (sNfL) may be useful to identify subclinical disease activity, according to an analysis from the APLIOS study (Bar-Or et al. Neurol Ther 2023;12:303-317). Read More
Vitamin D supplementation is routinely recommended for patients with multiple sclerosis. However, numerous studies have reported that there is no benefit on clinical or MRI outcomes associated with high-dose vitamin D. Read More
Click here to watch Dr. Virender Bhan discuss the case and the responses to the survey.
Amanda, 31, a computer programmer was diagnosed with RRMS in 2014. She was initially treated with glatiramer acetate, but experienced ongoing disease activity. She was switched to fingolimod in 2016 and was clinically and radiologically stable for three years. Read More